Omkar Pharmachem Limited (BOM:532167)
India
· Delayed Price · Currency is INR 30.00
0.00 (0.00%)
At close: Feb 3, 2025
Omkar Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | - | 0.72 | 1.33 | 2.11 | 0.44 | 0.41 | Upgrade
|
| Cash & Short-Term Investments | 1.78 | 0.72 | 1.33 | 2.11 | 0.44 | 0.41 | Upgrade
|
| Cash Growth | 116.99% | -46.04% | -37.23% | 381.55% | 7.60% | 101.04% | Upgrade
|
| Accounts Receivable | - | 0.49 | 0.49 | - | - | 0.14 | Upgrade
|
| Receivables | - | 0.49 | 0.49 | - | - | 0.14 | Upgrade
|
| Other Current Assets | - | 0.64 | 0.81 | 0.81 | 0.27 | 0.05 | Upgrade
|
| Total Current Assets | - | 1.84 | 2.62 | 2.92 | 0.71 | 0.59 | Upgrade
|
| Property, Plant & Equipment | - | 0.07 | 0.04 | 0.06 | 0.02 | 0.03 | Upgrade
|
| Long-Term Investments | - | 93 | 93 | 93 | 93 | 93 | Upgrade
|
| Other Intangible Assets | - | 0.02 | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | - | 1 | 1.64 | 2.31 | 2.58 | 0.01 | Upgrade
|
| Total Assets | - | 95.92 | 97.3 | 98.29 | 96.3 | 93.62 | Upgrade
|
| Accrued Expenses | - | 0.5 | 0.59 | 0.49 | 0.6 | 0.49 | Upgrade
|
| Short-Term Debt | - | 3.03 | 6.21 | 9.3 | 9.02 | 8.65 | Upgrade
|
| Other Current Liabilities | - | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | Upgrade
|
| Total Current Liabilities | - | 3.6 | 6.86 | 9.84 | 9.68 | 9.21 | Upgrade
|
| Total Liabilities | - | 3.6 | 6.86 | 9.84 | 9.68 | 9.21 | Upgrade
|
| Common Stock | - | 100.83 | 100.83 | 100.83 | 100.83 | 100.83 | Upgrade
|
| Retained Earnings | - | -8.51 | -10.4 | -12.38 | -14.21 | -16.42 | Upgrade
|
| Comprehensive Income & Other | - | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shareholders' Equity | 93.7 | 92.33 | 90.44 | 88.46 | 86.63 | 84.41 | Upgrade
|
| Total Liabilities & Equity | - | 95.92 | 97.3 | 98.29 | 96.3 | 93.62 | Upgrade
|
| Total Debt | 3.03 | 3.03 | 6.21 | 9.3 | 9.02 | 8.65 | Upgrade
|
| Net Cash (Debt) | -1.26 | -2.32 | -4.89 | -7.18 | -8.59 | -8.25 | Upgrade
|
| Net Cash Per Share | -0.12 | -0.23 | -0.48 | -0.71 | -0.85 | -0.82 | Upgrade
|
| Filing Date Shares Outstanding | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | Upgrade
|
| Total Common Shares Outstanding | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | Upgrade
|
| Working Capital | - | -1.76 | -4.24 | -6.91 | -8.97 | -8.62 | Upgrade
|
| Book Value Per Share | 9.30 | 9.16 | 8.97 | 8.77 | 8.59 | 8.37 | Upgrade
|
| Tangible Book Value | 93.7 | 92.31 | 90.44 | 88.46 | 86.63 | 84.41 | Upgrade
|
| Tangible Book Value Per Share | 9.30 | 9.15 | 8.97 | 8.77 | 8.59 | 8.37 | Upgrade
|
| Machinery | - | 0.27 | 0.2 | 0.2 | 0.13 | 0.13 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.